INSP - Inspire Medical Systems, Inc.
| Previous Close | 45.31 |
| Open | 45.31 |
| Bid | 0.00 x 800 |
| Ask | 49.23 x 800 |
| Day's Range | 39.00 - 45.31 |
| 52 Week Range | 22.50 - 57.87 |
| Volume | 274,052 |
| Avg. Volume | 156,230 |
| Market Cap | 866.716M |
| Beta (3Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 53.67 |
- GlobeNewswire•5 days ago
Inspire Medical Systems, Inc. to Present at the 30th Annual Piper Jaffray Healthcare Conference
MINNEAPOLIS, Nov. 14, 2018 -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative.
- GlobeNewswire•13 days ago
Inspire Medical Systems, Inc. Announces Third Quarter 2018 Financial Results and Updates 2018 Outlook
MINNEAPOLIS, Nov. 06, 2018 -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative.
- GlobeNewswire•25 days ago
Inspire Medical Systems, Inc. to Present at the Stifel 2018 Healthcare Conference
Inspire Medical Systems, Inc. (INSP) ("Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea (OSA), announced today that its management team will be presenting at the Stifel 2018 Healthcare Conference on November 13, 2018 at the Lotte New York Palace Hotel in New York. Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea.
- GlobeNewswire•last month
Inspire Medical Systems, Inc. Announces Presentation of Clinical Efficacy Data for Inspire Therapy for Treatment of Obstructive Sleep Apnea at Annual ENT Surgeon Conference
Inspire Medical Systems, Inc. (INSP) ("Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea (OSA), announced today that physicians presented updates from multiple clinical trials evaluating Inspire therapy for the treatment of OSA at the American Academy of Otolaryngology – Head Neck Surgery (AAO-HNSF) Annual Meeting and OTO Experience 2018, which took place from October 7 - 10, 2018, in Atlanta, GA. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
- GlobeNewswire•last month
Inspire Medical Systems, Inc. to Report Third Quarter 2018 Financial Results November 6, 2018
MINNEAPOLIS, Oct. 16, 2018 -- Inspire Medical Systems, Inc. (“Inspire”) (NYSE: INSP), a medical technology company focused on the development and commercialization of.
- GlobeNewswire•last month
Inspire Medical Systems, Inc. Announces First Implant of New Sensing Lead in Europe
Inspire Medical Systems, Inc. (INSP) ("Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea (OSA), announced today the first implant of its new sensing lead (model number 4340) in Europe. The implant was successfully completed by Dr. Joachim Maurer, University Hospital, Mannheim, Germany, who has now overseen 80 Inspire therapy cases. Dr. Maurer is an Ear Nose and Throat (ENT) surgeon and Head of the Sleep Disorders Center.
- GlobeNewswire•2 months ago
Inspire Medical Systems, Inc. to Have Significant Presence at American Academy of Otolaryngology – Head Neck Surgery Annual Meeting & OTO Experience 2018
MINNEAPOLIS, Oct. 02, 2018 -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire”), a medical technology company focused on the development and commercialization of.
- Benzinga•4 months ago
Benzinga's Daily Biotech Pulse: Acceleron On Fast Lane, OncoCyte's Accurate Diagnosis, Inspire Medical Gets Aetna Coverage
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on July 9) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) Arrowhead Pharmaceuticals ...
- ACCESSWIRE•6 months ago
Free Daily Technical Summary Reports on LivaNova and Three Other Medical Equipment Stocks
WallStEquities.com monitors four Medical Appliances and Equipment stocks, namely: Globus Medical Inc. (NYSE: GMED), Inspire Medical Systems Inc. (NYSE: INSP), InspireMD Inc. (NYSE AMER: NSPR), and LivaNova PLC (NASDAQ: LIVN). Audubon, Pennsylvania headquartered Globus Medical Inc.'s shares recorded a trading volume of 636,640 shares last Friday.
- Benzinga•6 months ago
Inspire Medical Has $10B Annual Market Opportunity, Stifel Says In Bullish Initiation
Not a month into Inspire Medical Systems Inc (NYSE: INSP)’s life as a publicly traded company, the Street is coming to consensus. “We believe Inspire Medical Systems is well positioned to disrupt the obstructive sleep apnea market over the next several years,” Block said in a note.
- InvestorPlace•6 months ago
3 New Healthcare Stocks to Buy Right Now
As we continue to age and populations grow, demand for new and innovative healthcare solutions is only growing as well. Already preliminary data shows that MOR208 could be a better therapy than the so-called cell therapies when used in combination to cure cancer.
- Benzinga•7 months ago
Inspire Medical Systems Goes Public
The medical technology company Inspire Medical Systems, Inc. (NYSE: INSP ) went public Thursday on the New York Stock Exchange. What Happened The company issued 6.75 million shares priced at $16 each. ...
